Pelish Henry E.

Chief Scientific Officer · SEC CIK 2029477
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$12.97M
43 trades
Net flow
−$12.97M
Net selling
Total filings
81
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Apr 13, 2026 ΔOwn +4.7%
+$86.1K
3,093 sh @ $28
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Apr 13, 2026 ΔOwn −3.2%

Pelish Henry E. sold $228.7K of NUVL, trimming their stake 3%.

−$228.7K
2,193 sh @ $104
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Apr 13, 2026 ΔOwn −1.4%

Pelish Henry E. sold $94.5K of NUVL, trimming their stake 1%.

−$94.5K
900 sh @ $105
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −1.1%

Pelish Henry E. sold $78.7K of NUVL, trimming their stake 1%.

−$78.7K
804 sh @ $98
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −3.7%

Pelish Henry E. sold $256.7K of NUVL, trimming their stake 4%.

−$256.7K
2,597 sh @ $99
Advertisement
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −2.5%

Pelish Henry E. sold $169.8K of NUVL, trimming their stake 3%.

−$169.8K
1,703 sh @ $100
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Mar 16, 2026 ΔOwn +10%
+$160.1K
8,456 sh @ $19
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Mar 16, 2026 ΔOwn +1.9%
+$48.8K
1,754 sh @ $28
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Mar 16, 2026 ΔOwn +4.4%
+$121K
4,125 sh @ $29
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Mar 16, 2026 ΔOwn +3.1%
+$216K
2,985 sh @ $72
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −24%

Pelish Henry E. sold $2.37M of NUVL, trimming their stake 24%.

−$2.37M
24,189 sh @ $98
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −7.2%

Pelish Henry E. sold $541.9K of NUVL, trimming their stake 7%.

−$541.9K
5,505 sh @ $98
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −0.4%

Pelish Henry E. sold $30.3K of NUVL.

−$30.3K
306 sh @ $99
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −1.6%

Pelish Henry E. sold $107K of NUVL, trimming their stake 2%.

−$107K
1,106 sh @ $97
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −2.0%

Pelish Henry E. sold $133.2K of NUVL, trimming their stake 2%.

−$133.2K
1,369 sh @ $97
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −0.3%

Pelish Henry E. sold $18.6K of NUVL.

−$18.6K
189 sh @ $98
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −0.7%

Pelish Henry E. sold $49.3K of NUVL, trimming their stake 1%.

−$49.3K
513 sh @ $96
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −0.9%

Pelish Henry E. sold $63.9K of NUVL, trimming their stake 1%.

−$63.9K
660 sh @ $97
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −1.6%

Pelish Henry E. sold $111.4K of NUVL, trimming their stake 2%.

−$111.4K
1,137 sh @ $98
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −0.3%

Pelish Henry E. sold $18.3K of NUVL.

−$18.3K
186 sh @ $99
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Dec 23, 2025 ΔOwn +7.7%
+$5.5K
5,085 sh @ $1
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Oct 17, 2025 ΔOwn +5.6%
+$69.4K
3,668 sh @ $19
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Oct 17, 2025 ΔOwn +11%
+$208.7K
7,495 sh @ $28
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Oct 17, 2025 ΔOwn +3.9%
+$220.1K
3,042 sh @ $72
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Oct 17, 2025 ΔOwn −18%

Pelish Henry E. sold $1.28M of NUVL, trimming their stake 18%.

−$1.28M
14,205 sh @ $90
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Oct 15, 2025 ΔOwn +1.1%
+$13.8K
731 sh @ $19
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Oct 15, 2025 ΔOwn +1.3%
+$24.4K
877 sh @ $28
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Oct 15, 2025 ΔOwn +1.2%
+$24.2K
825 sh @ $29
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Oct 15, 2025 ΔOwn −1.7%

Pelish Henry E. sold $99.2K of NUVL, trimming their stake 2%.

−$99.2K
1,167 sh @ $85

Frequently asked questions

How is Pelish Henry E.'s win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Pelish Henry E.'s SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.